They have even increased by 5 without the dollar effect

Read the latest results from Intel, can feel, unfortunately, relatively optimistic on the future of pessimism, to borrow a phrase of Jean Rostand. A priori all goes well. If one ignores the load of the $ 1.45 billion fine imposed by the Commission, the earnings per share reached 18 cents, against 8 expected by analysts. The improvement of the sales of the second quarter from the first same is the highest ever recorded by the Santa-Clara Group since 1988. What to Paul Otellini, Executive Director, building on a second half even more dynamic. Knowing that Intel provides 4 computers 5 chips in the world, this trust seems to best omen for the rest of the industry. From there to sing the melody of happiness, there are still a few couplets to write, including publications from IBM, Google and Microsoft to come. Goldman Sachs made blunder by relying on an 8 fall in technology spending this year. Especially, it is the general public and his new passion for netbooks that a bit of blue sky emerges. The margins by these inexpensive materials are relatively low. Businesses they keep the weapon at the foot and seem not ready to renew their equipment, especially in Europe where sales of Intel from last year fell 34 8 in Asia and 14 in America. Everything is perhaps not so well.

Happy Rouletabille

Systematic forecasters follow closely the facts and actions of the Swedish giant SKF. These modern Rouletabille collect carefully the valuable clues provided by the global master of ball bearings, one of the barometers of the global demand in industry and services. And where his boss, Tom Johnstone, was a "very dark and long tunnel" three months ago, it now predicts a stabilization of the demand at the current level. The oracle was correct to shower the reckless, because the second quarter saw an acceleration of the decline in the volume of activity, at 30.8 on an annual basis. Fortunately, SKF knows friction optimization: not only the fall in sales is amortized by foreign exchange effects, but the quarterly cash flow managed to beat records. It must be said that the decline in production is more dizzying than that of sales to reduce inventories, revenues slightly less than 23 of sales, against a target of 18 in the medium term. The firm of Gothenburg has cut in its dividend and cut in its workforce. Investors want to adversity-resistant: the course grew 33 from the beginning, almost 23 on average for the European metallurgy.

Voltaire and the baths of mouth

The laboratories are well placed, since Voltaire, to know that there is no more suspect than a doctor who died not of old age. They are therefore now traversing the crisis developed relatively free from shock by their war treasures and almost compulsory expenditure that feed. This does not mean that they do not treat their own headaches. To counter the threat of generics and a search which patina, some have chosen mégadeals as Roche, Merck or Pfizer, another diversification. This direction, that Johnson & Johnson was only to take in 2006 by buying the consumer division of Pfizer, proves once more that it was good. If the pharmacy sales fell by 13 due to the loss of two patents, those of the consumer, relaxed by the eternal success Listerine mouth baths, limited their decline to 4.5. They have even increased by 5 without the dollar effect. The third foot in medical devices shown, him too, his firmness, exceeding for the first time in ten years the performance of the drug. The cost control has both the effectiveness of the order, which should lead J & J this year to profit by action comparable to that of last year.